CareDx Inc reports results for the quarter ended June 30 - Earnings Summary

• CareDx Inc CDNA.OQ reported quarterly adjusted earnings of 10 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 25 cents. The mean expectation of eight analysts for the quarter was for earnings of 12 cents per share. Wall Street expected results to range from 10 cents to 14 cents per share.

• Revenue fell 6.1% to $86.68 million from a year ago; analysts expected $90.62 million.

• CareDx Inc's reported EPS for the quarter was a loss of 16 cents​.

• The company reported a quarterly loss of $8.57 million.

• CareDx Inc shares had fallen by 34.2% this quarter and lost 40.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 1.4% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for CareDx Inc is $26.00, about 50.6% above its last closing price of $12.85

This summary was machine generated from LSEG data August 6 at 09:02 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)